Table_5_Genome-Wide Identification of Rare and Common Variants Driving Triglyceride Levels in a Nevada Population.xlsx by Robert W. Read (6248582)

“…The study identified 549 significant single-variant associations (p < 8.75 × 10^–9), many in chromosome 11’s triglyceride hotspot: ZPR1, BUD13, APOC3, APOA5. A well-known protective loss-of-function variant in APOC3 (R19X) was associated with a 51% decrease in triglyceride levels in the cohort. …”

DataSheet5_A drilling wellbore pressure calculation model considering the effect of gas dissolution and suspension.xlsx by Wenbo Zhang (498386)

Image_5_A Prognostic Model of Differentiated Thyroid Cancer Based on Up-Regulated Glycolysis-Related Genes.tif by Min Wu (41570)

Table 5_Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2.xlsx by Xiaoqin Lu (3121482)

“…High-frequency mutations were found in PTEN, ARID1A, and UBR4. Genes like COX5B and MS4A1 emerged as potential predictors of clinical outcomes and therapeutic response. …”

Video_5_ECG Imaging to Detect the Site of Ventricular Ischemia Using Torso Electrodes: A Computational Study.AVI by Vinay Kara (6320150)

Table_5_A Prognostic Model of Differentiated Thyroid Cancer Based on Up-Regulated Glycolysis-Related Genes.xlsx by Min Wu (41570)

Video_5_ECG Imaging to Detect the Site of Ventricular Ischemia Using Torso Electrodes: A Computational Study.AVI by Vinay Kara (6320150)

Supplementary Figure S8 from CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling by Feng Jiang (95012)

Effects of truncated A2PP peptides on <i>M</i>. <i>hyorhinis</i> infection. by Shiqin Yuan (848670)

Table_3_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

“…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”

Table_2_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

“…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”

Image_1_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

“…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”

Table_5_Trichohyalin gene expression is negatively correlated with the severity of dermatitis in a canine atopic dermatitis model.XLSX by Rosanna Marsella (8606172)

“…Introduction<p>Canine atopic dermatitis (AD) closely mimics human AD and is recognized as a beneficial animal model. House dust mites (HDM) are a common allergen for both species. …”

Image_4_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

“…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”

Table_1_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

“…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”

Image_2_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

“…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”

Occupational risk factors for asthma exacerbation in adults: a five-year follow-up of the Norwegian Telemark study cohort by N Zivadinovic (21239948)

“…</p> <p><b><i>Methods:</i></b> In a prospective study of respiratory health in Telemark, Norway, 1857 adult participants with physician-diagnosed asthma were invited to participate in a follow-up survey. …”

5.HT_1A binding difference between known cause of death (KCOD) controls and SIDS. by Hannah C. Kinney (10280975)

“…When SIDS is compared to all KCOD controls, the HG, NTS, and MAO show a significant mean difference in 5-HT_1A receptor binding. …”

Image_3_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

“…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”

Efficacy of Neonatal HBV Vaccination on Liver Cancer and Other Liver Diseases over 30-Year Follow-up of the Qidong Hepatitis B Intervention Study: A Cluster Randomized Controlled T... by Chunfeng Qu (114656)

“…The estimated efficacy of catch-up vaccination on HBsAg seroprevalence in early adulthood was 21% (95% CI 10%–30%), substantially weaker than that of the neonatal vaccination (72%, 95% CI 68%–75%). Receiving a booster at age 10–14 years decreased HBsAg seroprevalence if participants were born to HBsAg-positive mothers (hazard ratio [HR] = 0.68, 95% CI 0.47–0.97). …”